The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - NMC Health plc

14 Feb 2020 13:49

RNS Number : 0998D
Franklin Resources, Inc
14 February 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Franklin Resources, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NMC Health plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

13 February 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

236,800

0.11%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

236,800

0.11%

 

 

 

 

 

 

 

Class of relevant security:

 

Convertible bond 2025

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

21,400,000

5.94%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

21,400,000

5.94%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

10p ordinary

Transfer in of discretionary holdings

627 shares

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

 

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

14 February 2020

Contact name:

Cathy Johnson

Telephone number*:

954-527-7580

subsshholder@franklintempleton.com

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETXZLFFBLLZBBQ
Date   Source Headline
27th Jan 201712:15 pmRNSDirector/PDMR Shareholding
12th Jan 20173:00 pmRNSDirector/PDMR Notification
29th Dec 20161:34 pmRNSResult of General Meeting
19th Dec 20162:19 pmRNSPDMR notification
19th Dec 20161:11 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
19th Dec 20169:06 amRNSTotal Voting Rights
14th Dec 20163:44 pmRNSResults of Placing
14th Dec 20162:11 pmRNSRevised Remuneration Policy - Publ. of Circular
14th Dec 20168:34 amRNSCircular Publication and General Meeting Notice
14th Dec 20168:33 amRNSProposed Placing of New Ordinary Shares
14th Dec 20168:33 amRNSAcquisition
23rd Nov 20165:05 pmRNSHolding(s) in Company
23rd Nov 20164:56 pmRNSHolding(s) in Company
23rd Nov 20164:55 pmRNSHolding(s) in Company
23rd Nov 20164:53 pmRNSHolding(s) in Company
9th Nov 20169:44 amRNSHolding(s) in Company
25th Oct 20164:10 pmRNSDirector/PDMR Shareholding
30th Aug 20167:00 amRNSNMC HEALTH ENTERS SAUDI ARABIAN MARKET
24th Aug 20167:00 amRNSHalf-year Report
23rd Aug 201611:06 amRNSNotice of Results
22nd Jul 20169:52 amRNSDirector/PDMR Shareholding
3rd Jun 20165:18 pmRNSResults of voting at Annual General Meeting
6th May 20162:54 pmRNSAGM and Publication of Circular
13th Apr 20169:49 amRNSDirector/PDMR Shareholding
15th Mar 20164:00 pmRNSDirector/PDMR Shareholding
14th Mar 20167:00 amRNSFinal Results
8th Mar 201610:05 amRNSNotice of Results
8th Mar 20167:00 amRNSNMC Royal Hospital Officially Opened
1st Feb 201610:42 amRNSClosing acquisition of majority stake in Fakih IVF
26th Nov 20157:51 amRNSForm 8.5 (EPT/NON-RI)
24th Nov 20159:15 amRNSForm 8.5 (EPT/NON-RI)
24th Nov 20158:30 amRNSAcquisition
20th Nov 20157:54 amRNSForm 8.5 (EPT/NON-RI)
19th Nov 201510:56 amRNSForm 8.3 -NMC Health PLC
19th Nov 20159:51 amRNSUPDATE ON PROGRESS OF GROUP STRATEGY
18th Nov 20153:22 pmRNSForm 8.3 - Al Noor Hospitals Group PLC
17th Nov 20153:23 pmRNSForm 8.3 - NMC Health PLC
17th Nov 20152:52 pmRNSForm 8.3 - Al Noor Hospitals
17th Nov 20152:19 pmRNSForm 8.5 (EPT/RI) NMC Health Plc
17th Nov 201511:31 amRNSForm 8.5 (EPT/RI)
17th Nov 201511:00 amRNSForm 8.5 (EPT/RI) - NMC Health Plc
17th Nov 201510:25 amRNSForm 8.3 - NMC Health PLC
17th Nov 20159:42 amRNSForm 8.3 - Al Noor Hospitals Group PLC
17th Nov 20159:35 amRNSForm 8.3 - NMC Health Plc
16th Nov 20153:09 pmBUSForm 8.3 - NMC Health plc
16th Nov 20153:00 pmRNSForm 8.3 - Al Noor Hospitals Group plc
16th Nov 20152:24 pmRNSForm 8.3 - NMC Health PLC
16th Nov 201512:35 pmRNSForm 8.5 (EPT/RI) NMC Health Plc
16th Nov 201512:32 pmRNSRule 2.8 Announcement
16th Nov 201511:54 amBUSForm 8.3 - NMC Health Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.